Skip to main content

Table 1 Baseline demographic characteristics in the per-protocol population

From: A novel read methodology to evaluate the optimal dose of 68Ga-satoreotide trizoxetan as a PET imaging agent in patients with gastroenteropancreatic neuroendocrine tumours: a phase II clinical trial

Parameter Arm A (N = 8) Arm B (N = 8) Arm C (N = 8) Overall (N = 24)
Age, years 71.5 (54–84) 65.5 (60–72) 60.5 (48–76) 62.5 (48–84)
Sex     
 Male 6 (75.0) 3 (37.5) 7 (87.5) 16 (66.7)
 Female 2 (25.0) 5 (62.5) 1 (12.5) 8 (33.3)
Body weight, kg 81.0 (77–98) 87.5 (52–109) 87.5 (60–105) 85.0 (52–109)
Height, cm 175.5 (162–189) 171.0 (159–185) 177.5 (171–189) 176.0 (159–189)
BMI, kg/m2 26.4 (24–35) 28.8 (21–34) 26.6 (19–31) 26.7 (19–35)
ECOG performance status
 0 (normal activity) 7 (87.5) 7 (87.5) 7 (87.5) 21 (87.5)
 1 (restricted activity) 1 (12.5) 1 (12.5) 1 (12.5) 3 (12.5)
  1. Data are presented as n (%) or median (range). Percentages are calculated as n/N
  2. BMI body mass index, ECOG Eastern Cooperative Oncology Group